Analyst Patrick Trucchio of H.C. Wainwright reiterated a Buy rating on Sangamo Biosciences (SGMO – Research Report), retaining the price target ...

Astellas Pharma partners with Sangamo Therapeutics to license STAC-BBB, a neurotropic AAV capsid for neurological disease ...

Mitochondria, the cell’s energy centers, play a vital role in regulating cellular processes, including growth and survival.

Sangamo Therapeutics, Inc. has groundbreaking treatments for neuropathic pain and Hemophilia A. Click for my updated look at ...

Stock futures ticked up slightly, rebounding from the previous session’s losses, as the Federal Reserve forecasted persistent ...

Sangamo Therapeutics, Inc. , a genomic medicine company and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas"), today announced they have entered into a license agreement ...

A team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeutic ...

Tenaya’s share slump following the TN-201 data drop could be due to its “significantly lower” level of RNA expression in the ...

Scientists are literally shining a laser on the energy centers of cancer cells in an attempt to harm these sources of power ...

Landmark publication in leading ophthalmology research journal demonstrates the power of 4DMT’s Therapeutic Vector Evolution platform to invent ...

VectorY strengthens Leadership Team with appointment of Jim Scibetta as new CEO (Photo: Business Wire) ...